Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Global transmission of influenza viruses from humans to swine.

Nelson MI, Gramer MR, Vincent AL, Holmes EC.

J Gen Virol. 2012 Oct;93(Pt 10):2195-203. doi: 10.1099/vir.0.044974-0. Epub 2012 Jul 12.

2.

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study.

Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Mølbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA.

Lancet Infect Dis. 2012 Sep;12(9):687-95. doi: 10.1016/S1473-3099(12)70121-4. Epub 2012 Jun 26. Erratum in: Lancet Infect Dis. 2012 Sep;12(9):655.

PMID:
22738893
3.

Airborne transmission of influenza A/H5N1 virus between ferrets.

Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

Science. 2012 Jun 22;336(6088):1534-41. doi: 10.1126/science.1213362.

4.

Influenza: options to improve pandemic preparation.

Rappuoli R, Dormitzer PR.

Science. 2012 Jun 22;336(6088):1531-3. doi: 10.1126/science.1221466.

PMID:
22723412
5.

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.

Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y.

Nature. 2012 May 2;486(7403):420-8. doi: 10.1038/nature10831.

6.

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies.

Ekiert DC, Wilson IA.

Curr Opin Virol. 2012 Apr;2(2):134-41. doi: 10.1016/j.coviro.2012.02.005. Epub 2012 Mar 21. Review.

7.

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.

Nguyen HT, Fry AM, Gubareva LV.

Antivir Ther. 2012;17(1 Pt B):159-73. doi: 10.3851/IMP2067. Epub 2012 Feb 3. Review.

PMID:
22311680
8.

Residue Y161 of influenza virus hemagglutinin is involved in viral recognition of sialylated complexes from different hosts.

Wang M, Tscherne DM, McCullough C, Caffrey M, García-Sastre A, Rong L.

J Virol. 2012 Apr;86(8):4455-62. doi: 10.1128/JVI.07187-11. Epub 2012 Feb 1.

9.

Avian influenza H5N1 transmission in households, Indonesia.

Aditama TY, Samaan G, Kusriastuti R, Sampurno OD, Purba W, Misriyah, Santoso H, Bratasena A, Maruf A, Sariwati E, Setiawaty V, Glass K, Lokuge K, Kelly PM, Kandun IN.

PLoS One. 2012;7(1):e29971. doi: 10.1371/journal.pone.0029971. Epub 2012 Jan 4.

10.

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A.

Science. 2011 Aug 12;333(6044):850-6. doi: 10.1126/science.1205669. Epub 2011 Jul 28.

11.

Influenza virus assembly and budding.

Rossman JS, Lamb RA.

Virology. 2011 Mar 15;411(2):229-36. doi: 10.1016/j.virol.2010.12.003. Epub 2011 Jan 14. Review.

12.

Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding.

Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, van Riel D, Schrauwen EJ, Bestebroer TM, Koel B, Burke DF, Sutherland-Cash KH, Whittleston CS, Russell CA, Wales DJ, Smith DJ, Jonges M, Meijer A, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, García-Sastre A, Perez DR, Fouchier RA.

J Virol. 2010 Nov;84(22):11802-13. doi: 10.1128/JVI.01136-10. Epub 2010 Sep 15.

13.

Novel insights into proteolytic cleavage of influenza virus hemagglutinin.

Bertram S, Glowacka I, Steffen I, Kühl A, Pöhlmann S.

Rev Med Virol. 2010 Sep;20(5):298-310. doi: 10.1002/rmv.657. Review.

PMID:
20629046
14.

Drugs in development for influenza.

Boltz DA, Aldridge JR Jr, Webster RG, Govorkova EA.

Drugs. 2010 Jul 30;70(11):1349-62. doi: 10.2165/11537960-000000000-00000. Review.

PMID:
20614944
15.

The receptor-destroying enzyme of V. cholerae.

BURNET FM, STONE JD.

Aust J Exp Biol Med Sci. 1947 Sep;25(Pt 3):227-33. No abstract available.

PMID:
20270643
16.

Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.

Ayora-Talavera G, Shelton H, Scull MA, Ren J, Jones IM, Pickles RJ, Barclay WS.

PLoS One. 2009 Nov 18;4(11):e7836. doi: 10.1371/journal.pone.0007836.

17.
18.

Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.

Rossignol JF, La Frazia S, Chiappa L, Ciucci A, Santoro MG.

J Biol Chem. 2009 Oct 23;284(43):29798-808. doi: 10.1074/jbc.M109.029470. Epub 2009 Jul 28.

19.

Structure and function of the influenza A M2 proton channel.

Cady SD, Luo W, Hu F, Hong M.

Biochemistry. 2009 Aug 11;48(31):7356-64. doi: 10.1021/bi9008837.

20.

Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.

Magano J.

Chem Rev. 2009 Sep;109(9):4398-438. doi: 10.1021/cr800449m. Review. No abstract available.

PMID:
19537777

Supplemental Content

Support Center